Stereotactic Ablative Radiotherapy in the Management of Synchronous Early Stage Non-Small Cell Lung Cancers

被引：0
|
作者：
Ayoub, Z. [1 ]
Brooks, E. [1 ]
Welsh, J. [1 ]
Chen, A. [1 ]
Gandhi, S. [1 ]
Heymach, J. [1 ]
Vaporciyan, A. [1 ]
Chang, J. [1 ]
机构：
[1] UT MDACC, Houston, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Earlystage non-small cell lung cancer; Synchronous lesions; Stereotactic ablative radiation therapy;
D O I：
10.1016/j.jtho.2019.08.545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA06.10
引用
收藏
页码：S272 / S272
页数：1
相关论文
共 50 条
  • [21] Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early Stage Non-Small Cell Lung Cancer
    Jacobs, C.
    Gao, J.
    Wang, X.
    Mehta, K.
    Salama, J.
    Torok, J.
    Kelsey, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S611 - S612
  • [22] Stereotactic ablative radiotherapy as single treatment for early stage non-small cell lung cancer: A single institution analysis
    Zheng, Xiaoli
    Sun, Yanan
    Ye, Ke
    Fan, Chengcheng
    Wang, Xiaohui
    Yang, Yang
    Jiao, Ruidi
    Ge, Hong
    THORACIC CANCER, 2021, 12 (06) : 899 - 905
  • [23] Is stereotactic ablative radiotherapy an alternative to surgery in operable stage I non-small cell lung cancer?
    Filippi, Andrea Riccardo
    Franco, Pierfrancesco
    Ricardi, Umberto
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2014, 19 (04) : 275 - 279
  • [24] Stereotactic Ablative Radiotherapy for stage I non-small cell lung cancer: retrospective observational study
    Pieri, M.
    Cima, S.
    Capuccini, J.
    Labropoulos, F.
    Palombarini, M.
    Salvi, F.
    Compagnone, G.
    Deodato, F.
    Morganti, A. G.
    Frezza, G.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S636 - S636
  • [25] Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer: Rationale and Outcomes
    Iyengar, Puneeth
    Timmerman, Robert D.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (12): : 1514 - 1520
  • [26] Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
    Jacobs, Corbin D.
    Mehta, Kurren
    Gao, Junheng
    Wang, Xiaofei
    Salama, Joseph K.
    Kelsey, Chris R.
    Torok, Jordan A.
    CLINICAL LUNG CANCER, 2022, 23 (02) : 177 - 184
  • [27] Stereotactic ablative radiotherapy in combination with nivolumab for early stage operable non-small cell lung cancer: A phase II study
    Schvartsman, G.
    Amarato, Y.
    dos Santos, G. Prado
    Gomes, D. Bugano Diniz
    Koch, L. D. O.
    Bibas, B.
    Gomes, O., Jr.
    Campregher, P. Vidal
    Severino, P.
    Marti, L. Cavalheiro
    Ribeiro, V. Paes
    Leaden, L.
    Chate, R. Caruso
    de Campos, J. Ribas Milanez
    Sousa, V. A. Ramos
    Taranto, P.
    Moura, F. S.
    Terra, R. M.
    Rezende, A. C. P. D.
    Samano, M. Naoyuki
    ANNALS OF ONCOLOGY, 2024, 35 : S785 - S785
  • [28] Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more
    White, Abby
    Swanson, Scott J.
    JOURNAL OF THORACIC DISEASE, 2016, 8 : S399 - S405
  • [29] Worldwide Utilization of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?
    Alfaifi, S.
    Louie, A. V.
    Siva, S.
    Guckenberger, M.
    Videtic, G. M.
    Higgins, K.
    Alshafa, F.
    AlGhamdi, H.
    Gillespie, E. F.
    Stephans, K. L.
    Mula-Hussain, L.
    Harrow, S.
    Palma, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E1 - E2
  • [30] Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead
    Zhang, Jingze
    Kong, Li
    Jiao, Qinghua
    Li, Minghuan
    Yu, Jingming
    CANCER LETTERS, 2017, 401 : 46 - 52
12345